Univest
Univest
  • Markets

  • 3 Formulations and APIs, Chronic Therapy Brands and Fermentation Ingredients Stocks With a Strong Future Roadmap: Ipca Laboratories, Eris Lifesciences and Concord Biotech

    • October 21, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Formulations and APIs, Chronic Therapy Brands and Fermentation Ingredients Stocks With a Strong Future Roadmap: Ipca Laboratories, Eris Lifesciences and Concord Biotech

    Mid-cap Pharma Growth Stocks with a strong future roadmap: Ipca Laboratories, Eris Lifesciences and Concord Biotech. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.

    read more